Clinical Trial Update: Observational Studies in Cancer Associated Thrombosis for Rivaroxaban - United States Cohort

View source ↗

Summary

Observational US cohort study evaluating rivaroxaban for treatment and prophylaxis of venous thromboembolism in cancer patients; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Venous Thromboembolism

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Treatment of Venous Thromboembolism in Cancer Patients, Prophylaxis of Recurrent Venous Thromboembolism in Cancer Patients | Status: COMPLETED